FDA Approves CELECOXIB — Alembic Pharmaceuticals Inc.

Alembic Pharmaceuticals Inc. has received U.S. FDA approval for the generic version of the prescription osteoarthritis medication Celecoxib (API Name). This approval bolsters Alembic’s portfolio and positions the company to compete effectively in the generic pain management market segment.